Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments Clinical Trials in Hangzhou, Zhejiang

Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial